Work

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway

Year: 2006

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-05-0493

Authors: Deborah Chirnomas, Toshiyasu Taniguchi, Michelle de la Vega, Ami P. Vaidya, Maria Vasserman, Anne-Renee Hartman, Richard Kennedy, Rosemary Foster, Jennifer Mahoney, Michael V. Seiden, Alan D. D'Andrea

Institutions: Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute, Massachusetts General Hospital

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Public Health Service, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1060775982, Regulation of the Fanconi Anemia Pathway by Ubiquitination, Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE, G5259932395, Molecular Pathogenesis of Fanconi Anemia

OpenAlex ID: W2112791911

FWCI: 6.58

Cites: 62

Cited by: 207

Related to: 10